ZA202311374B - Improvements in or related to organic compounds - Google Patents

Improvements in or related to organic compounds

Info

Publication number
ZA202311374B
ZA202311374B ZA2023/11374A ZA202311374A ZA202311374B ZA 202311374 B ZA202311374 B ZA 202311374B ZA 2023/11374 A ZA2023/11374 A ZA 2023/11374A ZA 202311374 A ZA202311374 A ZA 202311374A ZA 202311374 B ZA202311374 B ZA 202311374B
Authority
ZA
South Africa
Prior art keywords
organic compounds
hydroxypropyltrialkylammonium
cationization
hyaluronate
salt
Prior art date
Application number
ZA2023/11374A
Other languages
English (en)
Inventor
Nathalie Joset
Nathalie Albrecht
Gerhard Brunner
Martin Lovchik
Marie Meunier
Romain Reynaud
Amandine Scandolera
Original Assignee
Givaudan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Sa filed Critical Givaudan Sa
Publication of ZA202311374B publication Critical patent/ZA202311374B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA2023/11374A 2021-07-15 2023-12-11 Improvements in or related to organic compounds ZA202311374B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2110211.6A GB202110211D0 (en) 2021-07-15 2021-07-15 Improvements in or related to organic compounds
PCT/EP2022/069882 WO2023285663A1 (en) 2021-07-15 2022-07-15 Improvements in or related to organic compounds

Publications (1)

Publication Number Publication Date
ZA202311374B true ZA202311374B (en) 2024-10-30

Family

ID=77443352

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2023/11374A ZA202311374B (en) 2021-07-15 2023-12-11 Improvements in or related to organic compounds

Country Status (13)

Country Link
US (1) US20250082561A1 (cg-RX-API-DMAC7.html)
EP (1) EP4370561A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024527398A (cg-RX-API-DMAC7.html)
KR (1) KR20240036040A (cg-RX-API-DMAC7.html)
CN (1) CN117693533A (cg-RX-API-DMAC7.html)
AU (1) AU2022312165A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023026192A2 (cg-RX-API-DMAC7.html)
CA (1) CA3222749A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023018381A2 (cg-RX-API-DMAC7.html)
GB (1) GB202110211D0 (cg-RX-API-DMAC7.html)
MX (1) MX2023014544A (cg-RX-API-DMAC7.html)
WO (1) WO2023285663A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202311374B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023122526A (ja) * 2022-02-22 2023-09-01 キユーピー株式会社 紫外線防御能向上剤、日焼け止め化粧料、及び紫外線防御能の増強方法
CN116041566B (zh) * 2022-12-18 2024-03-26 南京乐韬生物科技有限公司 一种阳离子化透明质酸盐的制备方法
WO2025096774A1 (en) * 2023-10-31 2025-05-08 Gorgeous Beauty Inc. Skin enhancing compositions and method of use
FR3166434A1 (fr) * 2024-09-13 2026-03-20 Cerevaa (Centre De Recherche De Valorisation Et Application) Méthode d’analyse de l’efficacité réparatrice d’un ingrédient cosmétique ou dermatologique sur les matières kératiniques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4220513B2 (ja) * 2005-12-01 2009-02-04 株式会社資生堂 カチオン化ヒアルロン酸
US8410076B2 (en) 2007-04-24 2013-04-02 Q.P. Corporation Cationized hyaluronic acid and/or salt thereof, method of producing the same, hair modifying agent, cuticle repairing agent, skin modifying agent, and cosmetic preparation each using the same
CN107556402A (zh) * 2017-10-18 2018-01-09 重庆工商大学 阳离子化透明质酸及其制备方法
CN112190502B (zh) * 2020-09-21 2023-05-16 山东省药学科学院 一种透明质酸季铵盐复合物

Also Published As

Publication number Publication date
BR112023026192A2 (pt) 2024-03-05
KR20240036040A (ko) 2024-03-19
MX2023014544A (es) 2024-01-31
CO2023018381A2 (es) 2024-01-25
EP4370561A1 (en) 2024-05-22
JP2024527398A (ja) 2024-07-24
CA3222749A1 (en) 2023-01-19
WO2023285663A1 (en) 2023-01-19
AU2022312165A1 (en) 2024-01-04
CN117693533A (zh) 2024-03-12
US20250082561A1 (en) 2025-03-13
GB202110211D0 (en) 2021-09-01

Similar Documents

Publication Publication Date Title
MX2023014544A (es) Mejoramientos en o relacionados con compuestos organicos.
ZA202002744B (en) Microbiocidal thiazole derivatives
MX2022001328A (es) Inhibidor de proteina quinasa quinasa activada por mitogeno (mek) para el tratamiento de apoplejia.
PH12021550105A1 (en) Highly sulfated fucans for the treatment of fibrous adhesions
JOP20180039A1 (ar) مثبطات pd-1/pd-l1
MX2019010261A (es) Derivados de oxadiazol microbicidas.
MX2018006309A (es) Particulas recubiertas y metodos de fabricacion y uso de las mismas.
WO2021053402A3 (en) Sulfonamide derivatives as ctps1 inhibitors
WO2022218941A3 (en) Compositions and methods for inhibiting ketohexokinase (khk)
MX2021003427A (es) Nuevos oxadiazoles.
WO2019108871A8 (en) Biofouling resistant coatings and methods of making and using the same
MX2022008665A (es) Nuevo derivado de pirazol.
MX2020007369A (es) Moduladores de la expresion de dnm2.
ZA202105742B (en) Modulators of malat1 expression
MX2022011077A (es) Variantes de transglutaminasa.
MY191930A (en) Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease
PH12019550138A1 (en) Pharmaceutical combinations for treating cancer
MX2021015333A (es) Combinaciones de inhibidores para el tratamiento de enfermedades relacionadas con la expresion de dux4.
MX2021015446A (es) Composiciones de melanoidina para proteger cultivos de plagas no fungicas.
CA3156248A1 (en) ANTI-CD37-MAYTANSINE ANTIBODY CONJUGATES AND METHODS OF USE THEREOF
CR20240052A (es) Composición nematicida
MX2021003481A (es) Compuesto heterociclico.
MX2024006105A (es) Nitroxolina para su uso en el tratamiento o prevencion de un neurofibroma plexiforme.
SG10201914108RA (en) Thermocleavable friction modifiers and methods thereof
WO2023014908A8 (en) Lpar1 antagonists and uses thereof